article · Discover Applied Sciences
Machine-learning models for heartbeat classification are usually validated within a single database, leaving the roles of sampling-rate and lead-configuration mismatch in cross-database failure unresolved. We ask how much of the gap is sampling, how much is imbalance, and how much is morphology. SARA-ML is a 34-feature framework in which every temporal descriptor is defined in milliseconds and every spectral descriptor as a dimensionless fraction, so feature vectors are comparable across sampling rates without resampling. A Random Forest and gradient-boosted trees were tested under three imbalance strategies (none; minority SMOTE to 20%; balanced downsampling/oversampling) using patient-independent grouped 5-fold cross-validation on MIT-BIH (47 subjects, 109,468 beats, 360 Hz) and applied unchanged to INCART (22 patients, 118,369 beats, 257 Hz). Ventricular sensitivity was 92 to 95% within MIT-BIH and 92.9% on the standard 44-record subset. Across databases, balanced rebalancing raised ventricular sensitivity from 70.5 to 82.3%. Transfer generalized to a third database (European ST-T, 250 Hz): ventricular sensitivity 90.6%, reverse transfer 94.8%. For burden quantification, cross-database positive predictive value was 0.96 (burden correlation 0.95). Removing morphology raised transfer sensitivity to 0.841, localizing the residual gap. Sample-count-independent features remove sampling rate as a degradation source, rebalancing removes much of the remainder, and the residual gap is morphological. The framework provides an interpretable, reproducible cross-database ECG baseline.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s42452-026-09459-3
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.